Treatment of<unk>  should be commenced immediately after the diagnosis has been made. Mortality of the disease correlates with the severity of the disease, which is usually assessed by the APACHE II/III score, and it ultimately assess the risk of developing multiple organ failure. The mortality rate due to<unk>  can be up to 60%. This highlights severity and fatal nature of the disease. Treatment should be prompt and physiological support should be set up. This involves resuscitation including the checking the patients airways, breathing and circulation and the management of multi-organ failure. The treatment should also involve broad spectrum antibiotic therapy. Due to the microfloral organisms which cause<unk> , treatment is difficult as the bacteria are often resistant to antibiotic treatment. Anti fungal treatment is also usually used in conjunction with antibiotic therapy. Depending on the severity of the infection, treatment duration can range from 48 hours up until 14 days. In addition, treatment of the condition also involves surgery to control the source of contamination and to also decrease the bacterial load which may be present. Surgical interventions can include drainage of fluid collections and abscesses, removal of necrotic tissue and preventative measures to prevent further infection. Furthermore, treatment should also be directed towards restoring the immunological imbalance. Early recognition and effective intervention are vital in achieving a successful outcome.
Tertiary peritonitis
Spontaneous bacterial peritonitis
Culture-bound syndrome
Abdominal compartment syndrome
Feline infectious peritonitis
Hemolytic–uremic syndrome
Proteus syndrome
Postcholecystectomy syndrome